← Evidence map

ArticleCardiovascular drugs and therapy2026

Beyond KPAQ Improvement: Reassessing the Clinical Meaning of Cilostazol-Rosuvastatin Combination Therapy in Symptomatic Peripheral Artery Disease.

Junao ChenPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42799864